Otsuka Frankfurt Research Institute GmbH clinical trials
A country office of Otsuka Holdings Co., Ltd.
The registry lists 6 studies whose lead sponsor is Otsuka Frankfurt Research Institute GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 1, 2013.
Status
- Completed
- 5
- Status unknown
- 1
Registry sponsor names on this page
- Otsuka Frankfurt Research Institute GmbH6 studies
Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Otsuka Holdings Co., Ltd. studies →
- Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical PracticeStatus unknownNCT01228682
Sponsor listed in the registry: Otsuka Frankfurt Research Institute GmbH
- ADAPT Adacolumn Pediatric Trial in Ulcerative ColitisCompletedNCT00781638Not applicable
Sponsor listed in the registry: Otsuka Frankfurt Research Institute GmbH
- A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed ConditionsCompletedNCT00773630Phase 1
Sponsor listed in the registry: Otsuka Frankfurt Research Institute GmbH
- CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative ColitisCompletedNCT00366925Not applicable
Sponsor listed in the registry: Otsuka Frankfurt Research Institute GmbH
- Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)CompletedNCT00219414Phase 4
Sponsor listed in the registry: Otsuka Frankfurt Research Institute GmbH
- Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary TuberculosisCompletedNCT00401271Phase 2
Sponsor listed in the registry: Otsuka Frankfurt Research Institute GmbH